corneal disease

Search with Google Search with Bing
Information
Disease name
corneal disease
Disease ID
DOID:10124
Description
"An eye disease that affects the cornea, which is the transparent surface of the eye that assists in light refraction." [url:https\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C26731]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID Status Phase Summary Start date Completion date
NCT04318132 Completed N/A Agreement and Precision Study of the Nidek Mirante January 25, 2020 December 30, 2021
NCT00006411 Completed N/A Cornea Donor Study January 10, 2000 July 2014
NCT00008541 Completed Evaluation and Treatment of Patients With Corneal and External Diseases January 2, 2001 March 6, 2009
NCT00357435 Completed Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases October 6, 2003 July 21, 2016
NCT00654888 Completed N/A Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy March 2005 February 2008
NCT00804505 Completed N/A Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study June 2008 December 2008
NCT01141985 Completed Early Phase 1 New Disposable Contact Lens Patient Interface For The Lensx Laser February 2010 December 2010
NCT01384487 Completed Nidek RS3000 Comparative Study June 2011 November 2011
NCT02050880 Completed OCT Agreement and Crossed Precision Study January 2014 June 2014
NCT04267991 Completed Corneal Densitometry Changes With Adenoviral SEI April 1, 2018 April 15, 2020
NCT05114928 Completed Correlation Between Q-value Changes and Progression of Pediatric Keratoconus. October 9, 2021 October 28, 2021
NCT02386774 Completed N/A Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa March 21, 2016 September 28, 2020
NCT04484402 Completed Phase 1/Phase 2 Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells October 3, 2016 December 30, 2019
NCT04475900 Completed Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics July 9, 2020 July 31, 2022
NCT03706443 Completed N/A Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops December 5, 2018 February 28, 2019
NCT03990506 Completed N/A Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus April 2, 2019 January 24, 2023
NCT05758753 Enrolling by invitation N/A QST for Corneal Nerve Function May 16, 2023 June 30, 2025
NCT06294015 Not yet recruiting Phase 4 Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops. March 2024 April 2026
NCT05581875 Not yet recruiting Phase 1/Phase 2 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory October 20, 2022 October 31, 2026
NCT05694247 Recruiting N/A Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness March 2024 March 2026
NCT05653921 Recruiting Prospective Study to Validate the Imaging Biomarker for NCP (R33) December 16, 2022 July 14, 2025
NCT04251143 Recruiting Dresden Corneal Disease and Treatment Study March 12, 2018 December 31, 2030
NCT06160960 Recruiting Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome October 9, 2017 October 1, 2024
NCT06101017 Recruiting Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease October 12, 2023 October 31, 2025
NCT05280275 Recruiting Phase 1/Phase 2 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible April 13, 2022 March 15, 2026
NCT05447845 Recruiting Rapid Computerized Visual Acuity Test January 1, 2019 December 31, 2022
NCT05573802 Recruiting Phase 1/Phase 2 A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma July 14, 2023 October 31, 2026
NCT00001310 Terminated Tissue Studies of Human Eye Diseases March 5, 1992 September 16, 2015
NCT04485858 Terminated N/A First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness January 3, 2021 June 1, 2023
NCT03619434 Unknown status N/A Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty February 1, 2019 December 26, 2021
NCT02148016 Unknown status Phase 1/Phase 2 Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation December 2012 September 2014
NCT05045053 Unknown status Phase 4 Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking February 1, 2021 January 2022
NCT05700864 Withdrawn Phase 1 NGF Treatment for Patients With Neuropathic Corneal Pain November 1, 2022 December 1, 2023
NCT02374723 Withdrawn Phase 1 Evaluation of Biosynthetic Constructs to Replace Donor Corneas June 2015 April 2016
NCT03421548 Withdrawn N/A Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1 November 2016 June 2020
Disase is a (Disease Ontology)
DOID:5614
Cross Reference ID (Disease Ontology)
ICD10CM:H18.9
Cross Reference ID (Disease Ontology)
ICD9CM:371.9
Cross Reference ID (Disease Ontology)
MESH:D003316
Cross Reference ID (Disease Ontology)
NCI:C26731
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:15250008
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0010034